New research highlights how hypertrophic adipocytes (enlarged fat cells) go beyond fat storage—they actively disrupt immune balance.
Here's the breakdown:
🔥 Hypoxia & HIF-1α
ReleaseExpanding adipose tissue creates a low-oxygen (hypoxic) environment, stabilizing HIF-1α. This triggers the release of VEGF and pro-inflammatory cytokines (IL-6, TNF-α), sparking inflammation and altering immune metabolism.
💉 VEGF & Angiogenesis
Hypertrophic adipocytes release VEGF, driving chaotic blood vessel growth to counteract hypoxia. This disorganized angiogenesis fuels local inflammation.
🌪️ Cytokine Storm
Enlarged fat cells flood the immune system with pro-inflammatory molecules (IL-1β, IL-6, TNF-α), recruiting macrophages and T cells that promote systemic inflammation and insulin resistance.
🔄 Altered Immune Milieu
The immune landscape shifts, favoring pro-inflammatory players (Th1, Th17, M1 macrophages) while suppressing anti-inflammatory cells (M2 macrophages, Tregs).
📚 Research connects these mechanisms with broader obesity-driven pathways, like extracellular vesicle signaling and fatty acid metabolism, showing how adipocyte-driven hypoxia sets the stage for chronic inflammation and systemic dysfunction.
✨ Takeaway: Adipocytes are not just passive players—they’re central to the immune chaos of obesity. Targeting these processes could reshape how we treat obesity-linked diseases!
Shaikh, S.R., et al., Emerging mechanisms of obesity-associated immune dysfunction. Nature Reviews Endocrinology, 2024. 20(3): p. 136-148.
Commentaires